HCA Healthcare, Inc. (NYSE:HCA) Shares Acquired by Mercer Global Advisors Inc. ADV

Mercer Global Advisors Inc. ADV increased its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 6.4% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 87,444 shares of the company’s stock after acquiring an additional 5,246 shares during the quarter. Mercer Global Advisors Inc. ADV’s holdings in HCA Healthcare were worth $28,064,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Bangor Savings Bank increased its stake in HCA Healthcare by 112.5% in the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after buying an additional 45 shares during the period. MFA Wealth Advisors LLC acquired a new position in HCA Healthcare in the 2nd quarter valued at approximately $27,000. Unique Wealth Strategies LLC acquired a new position in shares of HCA Healthcare during the 2nd quarter worth $28,000. GPS Wealth Strategies Group LLC increased its stake in shares of HCA Healthcare by 284.0% during the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after purchasing an additional 71 shares during the last quarter. Finally, LifeSteps Financial Inc. acquired a new position in shares of HCA Healthcare during the 1st quarter worth $33,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insiders Place Their Bets

In other news, SVP Kathryn A. Torres sold 1,857 shares of the stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $355.05, for a total value of $659,327.85. Following the completion of the transaction, the senior vice president now owns 17,755 shares of the company’s stock, valued at $6,303,912.75. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, SVP Kathryn A. Torres sold 1,857 shares of the firm’s stock in a transaction that occurred on Thursday, July 25th. The shares were sold at an average price of $355.05, for a total transaction of $659,327.85. Following the completion of the sale, the senior vice president now owns 17,755 shares of the company’s stock, valued at approximately $6,303,912.75. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the sale, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. The disclosure for this sale can be found here. Insiders have sold 17,202 shares of company stock worth $6,407,273 over the last ninety days. Corporate insiders own 1.60% of the company’s stock.

Analyst Ratings Changes

Several brokerages have recently commented on HCA. Morgan Stanley began coverage on shares of HCA Healthcare in a research note on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 price target on the stock. Barclays upped their price objective on shares of HCA Healthcare from $376.00 to $396.00 and gave the stock an “overweight” rating in a report on Wednesday, July 24th. Royal Bank of Canada upped their price objective on shares of HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a report on Friday, August 23rd. Robert W. Baird initiated coverage on shares of HCA Healthcare in a report on Thursday, May 30th. They set an “outperform” rating and a $396.00 price objective for the company. Finally, JPMorgan Chase & Co. increased their price target on shares of HCA Healthcare from $327.00 to $332.00 and gave the company a “neutral” rating in a report on Thursday, May 30th. Five equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and three have given a strong buy rating to the company’s stock. According to data from MarketBeat, HCA Healthcare currently has a consensus rating of “Moderate Buy” and an average target price of $359.89.

HCA Healthcare Stock Up 0.6 %

Shares of NYSE HCA opened at $399.89 on Thursday. The stock has a market cap of $104.74 billion, a P/E ratio of 19.93, a P/E/G ratio of 1.46 and a beta of 1.67. The firm has a 50 day moving average price of $367.24 and a 200 day moving average price of $339.56. The company has a debt-to-equity ratio of 27.11, a quick ratio of 0.94 and a current ratio of 1.06. HCA Healthcare, Inc. has a 52-week low of $215.96 and a 52-week high of $404.90.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The business had revenue of $17.49 billion for the quarter, compared to analyst estimates of $17.05 billion. During the same quarter in the previous year, the firm posted $4.29 earnings per share. The firm’s revenue for the quarter was up 10.3% on a year-over-year basis. Analysts expect that HCA Healthcare, Inc. will post 22.46 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Monday, September 16th will be paid a dividend of $0.66 per share. The ex-dividend date of this dividend is Monday, September 16th. This represents a $2.64 dividend on an annualized basis and a yield of 0.66%. HCA Healthcare’s payout ratio is 13.16%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.